在帕金森病中进行虚拟认知培训的综合生物合作机器人平台:OPERA项目的设计和方法
Cristina Polito1, Giulia Martinelli1, Sara Della Bella1
1Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione Don Carlo Gnocchi, Florence, Italy.
Frontiers in neurology
|February 11, 2026
概括
OPERA项目开发了PRoBio,这是一个使用虚拟现实和机器人技术进行个性化认知康复的新型平台,用于轻度认知障碍 (PD-MCI) 的帕金森病患者. 这种创新方法旨在改善PD-MCI患者的参与和结果.
科学领域:
- 神经科学是一个神经科学.
- 康复技术 康复技术 康复技术
- 人与机器人的交互
背景情况:
- 轻度认知障碍帕金森病 (PD-MCI) 影响多个认知领域,增加痴呆风险和减少自主性.
- 目前PD-MCI的认知培训缺乏标准化和引人入胜的工具.
- 需要创新技术来支持个性化认知康复.
研究的目的:
- 开发和评估PRoBio生物合作平台用于PD-MCI认知康复的可用性.
- 将虚拟现实 (VR),机器人辅助和生理监测集成到个性化康复系统中.
- 通过聚焦小组和生活实验室探索用户的期望和康复需求.
主要方法:
- OPERA项目涉及一个为期13个月的多中心调查,分为四个阶段.
- 第一个阶段:聚焦小组与PD患者,护理人员和专业人员一起定义需求.
- 第二阶段:开发PRoBio平台,集成VRRS和TIAGo机器人.
- 第三阶段:与健康受试者一起生活实验室,以在现实环境中评估可用性.
- 第四阶段:对10名PD-MCI患者进行可用性研究,他们接受了为期4周的认知康复计划.
主要成果:
- PRoBio平台是通过集成VRRS和TIAGo机器人来进行个性化认知练习来开发的.
- 通过实验室和PD-MCI患者的专门研究来评估可用性.
- 收集了生理和性能数据,以监测患者的状态和干预的有效性.
结论:
- OPERA项目成功开发了PRoBio平台,这是PD-MCI认知康复的新型生物合作系统.
- PRoBio集成了VR,机器人和生理反,以实现个性化和适应性干预.
- 这种方法为传统方法提供了更有吸引力的替代方案,并推动了人机交互研究的进步.
相关概念视频
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...